Indications and Purposes
| Laboratory Studies, Eszopiclone Tablets Administered At Bedtime Decreased Sleep Latency And Improved Sleep Maintenance. The Clinical Trials Performed In Support Of Efficacy Were Up To 6 Months In Duration. The Final Formal Assessments Of Sleep Latency And Maintenance Were Performed At 4 Weeks In The 6-Week Study (Adults Only), At The End Of Both 2-Week Studies (Elderly Only) And At The End Of The 6-Month Study (Adults Only). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Eszopiclone |
|
ZINC19632834 |